Braskem Pref ADR
BAK
Braskem Pref ADR (BAK) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HSBC | Downgraded | Buy → Hold | $1.50 from $6.50 | Sep 28, 2026 |
| UBS | Downgraded | Neutral → Sell | $1.50 from $4.00 | Sep 16, 2026 |
| JP Morgan | Downgraded | Overweight → Neutral | — | Jun 30, 2026 |
| Citigroup | Downgraded | Neutral → Sell | — | Jun 26, 2026 |
| UBS | Downgraded | Buy → Neutral | $3.80 from $5.10 | Sep 26, 2025 |
| JP Morgan | Maintained | Neutral | $5.00 from $6.00 | Aug 27, 2025 |
| UBS | Upgraded | Neutral → Buy | $10.00 from $7.70 | Sep 18, 2024 |
| JP Morgan | Maintained | Neutral | $9.50 from $10.00 | Sep 10, 2024 |
| Citigroup | Upgraded | Neutral → Buy | — | Aug 20, 2024 |
| JP Morgan | Maintained | Neutral | $10.00 from $11.00 | May 24, 2024 |
| JP Morgan | Downgraded | Overweight → Neutral | $11.00 from $11.50 | Jul 5, 2023 |
| Scotiabank | Upgraded | Sector Perform → Sector Outperform | $16.75 | May 8, 2023 |
Frequently asked questions
What is the latest analyst rating on BAK?
On Sep 28, 2026, HSBC downgraded Braskem Pref ADR to Hold with a price target of $1.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.